Improved medical instrument flow stop interface

Details for Australian Patent Application No. 2002307242 (hide)

Owner Cardinal Health 303, Inc.

Inventors Hurtado, Victor R.; Morris Matthew G.

Agent Davies Collison Cave

Pub. Number AU-B-2002307242

PCT Number PCT/US02/11317

PCT Pub. Number WO2002/089876

Priority 09/848,790 04.05.01 US

Filing date 11 April 2002

Wipo publication date 18 November 2002

Acceptance publication date 12 October 2006

International Classifications

A61M 5/142 (2006.01) Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way - Pressure infusion, e.g. using pumps

A61M 39/28 (2006.01) Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 09/848,790 04.05.01 US

1 May 2003 Application Open to Public Inspection

  Published as AU-B-2002307242

6 May 2004 Assignment before Grant

  ALARIS Medical Systems, Inc. The application has been assigned to ALARIS Medical Systems, Inc.

16 February 2006 Change of Name(s) of Applicant(s), Section 104

  ALARIS Medical Systems, Inc The name of the applicant has been changed to Cardinal Health 303, Inc

12 October 2006 Application Accepted

  Published as AU-B-2002307242

8 February 2007 Standard Patent Sealed

11 February 2010 Amendment Made

  The nature of the amendment is: Amend the patentee name from Cardinal Health 303, Inc. to CareFusion 303, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002307243-Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance

2002307241-GENES EXPRESSED IN BREAST CANCER AS PROGNOSTIC AND THERAPEUTIC TARGETS